Heritage Oak Wealth Advisors LLC Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Heritage Oak Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 561 shares of the medical equipment provider’s stock, valued at approximately $276,000.

Several other large investors have also bought and sold shares of ISRG. Silver Oak Securities Incorporated lifted its position in Intuitive Surgical by 545.3% in the 3rd quarter. Silver Oak Securities Incorporated now owns 1,581 shares of the medical equipment provider’s stock valued at $758,000 after acquiring an additional 1,336 shares in the last quarter. Schmidt P J Investment Management Inc. purchased a new position in shares of Intuitive Surgical in the third quarter worth $211,000. Mount Yale Investment Advisors LLC bought a new position in shares of Intuitive Surgical during the third quarter valued at $225,000. Rowlandmiller & PARTNERS.ADV boosted its position in shares of Intuitive Surgical by 8.1% during the third quarter. Rowlandmiller & PARTNERS.ADV now owns 2,278 shares of the medical equipment provider’s stock valued at $1,119,000 after buying an additional 170 shares during the last quarter. Finally, DT Investment Partners LLC boosted its position in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Amal M. Johnson sold 2,943 shares of the company’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at $5,441,507.50. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, EVP Brian Edward Miller sold 2,553 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the transaction, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Amal M. Johnson sold 2,943 shares of the business’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at approximately $5,441,507.50. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 52,192 shares of company stock worth $25,398,571. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $511.63 on Friday. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $523.34. The company’s fifty day moving average price is $486.71 and its 200-day moving average price is $440.96. The company has a market capitalization of $181.48 billion, a price-to-earnings ratio of 92.35, a PEG ratio of 5.40 and a beta of 1.39.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several research analyst reports. Robert W. Baird upped their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Truist Financial increased their price objective on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research report on Monday, October 14th. Raymond James boosted their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Stifel Nicolaus increased their price target on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. Finally, BTIG Research set a $535.00 price objective on Intuitive Surgical in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.